DK33591D0 - - Google Patents

Info

Publication number
DK33591D0
DK33591D0 DK33591A DK33591A DK33591D0 DK 33591 D0 DK33591 D0 DK 33591D0 DK 33591 A DK33591 A DK 33591A DK 33591 A DK33591 A DK 33591A DK 33591 D0 DK33591 D0 DK 33591D0
Authority
DK
Denmark
Application number
DK33591A
Other languages
Danish (da)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK33591A priority Critical patent/DK33591D0/da
Publication of DK33591D0 publication Critical patent/DK33591D0/da
Priority to PCT/DK1992/000059 priority patent/WO1992015611A1/fr
Priority to AU13729/92A priority patent/AU1372992A/en

Links

DK33591A 1991-02-27 1991-02-27 DK33591D0 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DK33591A DK33591D0 (fr) 1991-02-27 1991-02-27
PCT/DK1992/000059 WO1992015611A1 (fr) 1991-02-27 1992-02-27 Nouveaux derives d'insuline
AU13729/92A AU1372992A (en) 1991-02-27 1992-02-27 Novel insulin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK33591A DK33591D0 (fr) 1991-02-27 1991-02-27

Publications (1)

Publication Number Publication Date
DK33591D0 true DK33591D0 (fr) 1991-02-27

Family

ID=8092374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK33591A DK33591D0 (fr) 1991-02-27 1991-02-27

Country Status (3)

Country Link
AU (1) AU1372992A (fr)
DK (1) DK33591D0 (fr)
WO (1) WO1992015611A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316895D0 (en) * 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US6342225B1 (en) 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
ATE550041T1 (de) 2004-01-21 2012-04-15 Novo Nordisk Healthcare Ag Transglutaminase-vermittelte konjugation von peptiden
US20160083448A1 (en) * 2013-03-15 2016-03-24 Case Western Reserve University Site 2 insulin analogues
KR20190101963A (ko) * 2016-11-21 2019-09-02 케이스 웨스턴 리저브 유니버시티 안정성을 강화한 속효성 인슐린 유사체
WO2019034726A1 (fr) 2017-08-17 2019-02-21 Novo Nordisk A/S Nouveaux analogues d'insuline acylés et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
JPH03506023A (ja) * 1988-07-20 1991-12-26 ノボ　ノルデイスク　アクツイエセルスカプ ポリペプチド
EP0469084B1 (fr) * 1989-04-20 1995-04-05 Mount Sinai School Of Medicine Of The City University Of New York Analogues d'insuline hepatospecifiques
DK158390D0 (da) * 1990-07-02 1990-07-02 Novo Nordisk As Nye peptider

Also Published As

Publication number Publication date
WO1992015611A1 (fr) 1992-09-17
AU1372992A (en) 1992-10-06

Similar Documents

Publication Publication Date Title
DE9102607U1 (fr)
DE9102092U1 (fr)
DE9102748U1 (fr)
DE9102071U1 (fr)
DE9100936U1 (fr)
DE9101125U1 (fr)
DE9101850U1 (fr)
DE9101802U1 (fr)
DE9102035U1 (fr)
DE9101024U1 (fr)
DE9101743U1 (fr)
DE9101665U1 (fr)
DE9100980U1 (fr)
DE9101777U1 (fr)
DE9101424U1 (fr)
DE9101605U1 (fr)
DE9101846U1 (fr)
DE9102098U1 (fr)
DE9101483U1 (fr)
DE9100029U1 (fr)
DE9100251U1 (fr)
DE9102063U1 (fr)
DE9101751U1 (fr)
DE9102764U1 (fr)
DE9100108U1 (fr)

Legal Events

Date Code Title Description
ATS Application withdrawn